C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Acquires Shares of 6,017 Kenvue Inc. (NYSE:KVUE)

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new stake in Kenvue Inc. (NYSE:KVUE) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 6,017 shares of the company’s stock, valued at approximately $128,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Kestra Investment Management LLC bought a new stake in Kenvue in the fourth quarter valued at approximately $113,000. Atria Wealth Solutions Inc. raised its stake in Kenvue by 106.9% in the fourth quarter. Atria Wealth Solutions Inc. now owns 18,257 shares of the company’s stock valued at $390,000 after buying an additional 9,432 shares during the period. Kornitzer Capital Management Inc. KS increased its stake in shares of Kenvue by 5.3% during the fourth quarter. Kornitzer Capital Management Inc. KS now owns 86,720 shares of the company’s stock worth $1,851,000 after purchasing an additional 4,385 shares during the period. Venturi Wealth Management LLC increased its stake in shares of Kenvue by 78.2% during the fourth quarter. Venturi Wealth Management LLC now owns 10,737 shares of the company’s stock worth $229,000 after purchasing an additional 4,713 shares during the period. Finally, D.A. Davidson & CO. increased its stake in shares of Kenvue by 305.9% during the fourth quarter. D.A. Davidson & CO. now owns 157,247 shares of the company’s stock worth $3,357,000 after purchasing an additional 118,510 shares during the period. Institutional investors own 97.64% of the company’s stock.

Wall Street Analyst Weigh In

KVUE has been the topic of a number of recent research reports. UBS Group lowered their target price on Kenvue from $23.00 to $21.00 and set a “neutral” rating on the stock in a research note on Friday, February 7th. Canaccord Genuity Group lowered their target price on Kenvue from $27.00 to $24.00 and set a “buy” rating on the stock in a research note on Friday, February 7th. Deutsche Bank Aktiengesellschaft lowered Kenvue from a “buy” rating to a “hold” rating and lowered their target price for the stock from $25.00 to $24.00 in a research note on Thursday, December 12th. Barclays lowered their target price on Kenvue from $23.00 to $21.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and set a $24.00 target price on shares of Kenvue in a research note on Monday, February 3rd. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, Kenvue has a consensus rating of “Hold” and a consensus target price of $23.00.

Kenvue Trading Up 0.5 %

Shares of KVUE stock opened at $22.38 on Friday. The stock’s fifty day moving average price is $21.29 and its two-hundred day moving average price is $22.14. The company has a market cap of $42.90 billion, a PE ratio of 42.22, a P/E/G ratio of 2.57 and a beta of 1.45. Kenvue Inc. has a fifty-two week low of $17.67 and a fifty-two week high of $24.46. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 1.00.

Kenvue (NYSE:KVUE) last issued its earnings results on Thursday, February 6th. The company reported $0.26 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.26. Kenvue had a return on equity of 20.97% and a net margin of 6.66%. Equities analysts predict that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, February 26th. Shareholders of record on Wednesday, February 12th will be issued a $0.205 dividend. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.66%. The ex-dividend date of this dividend is Wednesday, February 12th. Kenvue’s dividend payout ratio is presently 154.72%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.